Posted by Clinical Lab Products | Sep 30, 2009 | Miscellaneous |
Sequenom Inc announced the completion of the independent investigation by a special committee of independent directors related to the test data and results for the company’s noninvasive prenatal test for Trisomy 21 (Down syndrome).
Read MorePosted by Clinical Lab Products | Sep 28, 2009 | Miscellaneous |
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the FDA to market its Xpert HemosIL FII & FV test. The test detects Factor II (FII) and Factor V Leiden (FV) genetic variations associated with thrombophilia, an increased risk of blood clots (thrombosis).
Read MorePosted by Clinical Lab Products | Sep 25, 2009 | Cancer, Miscellaneous |
Axial Biotech Inc, a company personalizing spine care through the development of molecular diagnostics, announced that its SCOLISCORE AIS Prognostic Test is now being made available to spine specialists in the United States.
Read MorePosted by Clinical Lab Products | Sep 21, 2009 | Miscellaneous |
Sequenom Inc announces that the company’s first laboratory developed test, the SensiGene Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom.
Read MorePosted by Clinical Lab Products | Sep 8, 2009 | Miscellaneous |
Luminex Corp announces that it has received 510(k) clearance from the FDA for a new cystic fibrosis (CF) test: the xTAG Cystic Fibrosis 39 Kit v2. The newly cleared xTAG test detects for 39 CF-causing gene mutations.
Read More